Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis

30 Jan 2023

Abstract excerpt

From the perspective of precision medicine, the challenge for the future is to improve the accuracy of diagnosis, prognosis, and prediction of therapeutic responses through the identification of biomarkers. In this framework, the omics sciences (genomics, transcriptomics, proteomics, and metabolomics) and their combined use represent innovative approaches for the exploration of the complexity and heterogeneity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Multiple Sclerosis Research Studies
Share to Rheumatoid Arthritis Research and Therapies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36793897
DOI: 10.3389/fgene.2023.1076421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisPMID 36793897Read ↗

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read ↗

Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicineSemantic proximity Read ↗

Metabolomics in multiple sclerosisSemantic proximity Read ↗

Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative DiseasesSemantic proximity Read ↗

Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Semantic proximity Read ↗

Multiple sclerosis: individualized disease susceptibility and therapy response.Semantic proximity Read ↗

Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.Semantic proximity Read ↗

Machine learning and multi-omics in precision medicine for ME/CFSSemantic proximity Read ↗

Decoding the molecular and cellular aspects of multiple sclerosis: From diagnosis to therapeutic strategiesSemantic proximity Read ↗

Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosisSemantic proximity Read ↗

Predicting response to disease modifying treatment in multiple sclerosisSemantic proximity Read ↗

United Europeans for development of pharmacogenomics in multiple sclerosis network.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.